Navigation Links
UAB oncologists: HPV vaccine protects from cancer recurrence
Date:3/16/2010

BIRMINGHAM, Ala. A vaccine designed to prevent cervical cancer also may protect females from post-surgical recurrence of the disease, according to researchers at the University of Alabama at Birmingham (UAB).

A new study shows that the Gardasil vaccine reduces the likelihood of human papillomavirus (HPV)-related disease recurring after teen and adult women already have had surgery to remove cancer or certain pre-cancerous changes, said Warner Huh, M.D., an associate professor in the UAB Division of Gynecologic Oncology and lead presenter on the study.

The findings were announced March 15 at the annual meeting of the Society of Gynecological Oncologists in Chicago.

The study shows that Gardasil reduces by approximately 40 percent the chances that more cancer or pre-cancerous changes will occur in the cervix, vagina and vulva up to 3.8 years after a female has surgery for one of those conditions.

Huh said the findings are important because they answer a question many women and their doctors have been asking does an HPV vaccine help treat virus-related changes in the body after women have surgery to treat similar changes?

"Based on this study, the data is compelling and suggests it does help to treat virus-related changes," Huh said. "Knowing that Gardasil also may offer postoperative protection from recurrent disease will be crucial in follow-up care and overall health planning for teens and women."

The vaccine is approved to fight the four HPV strains believed to cause 70 percent of cervical cancers and more than 90 percent of genital warts

The study involved 17,622 women ages 15 to 26 from two clinical trials, some who were vaccinated and some who were not. Hundreds of study participants had surgery to remove cancer or certain pre-cancerous changes of the cervix, vagina and vulva and to remove genital warts.

Huh said the results are encouraging because patients treated for HPV-related disease are known to be at higher risk for contracting the same disease post-operatively. Reducing the risk and need of a secondary procedure is an important step in improving women's care, he said.


'/>"/>

Contact: Troy Goodman
tdgoodman@uab.edu
205-934-8938
University of Alabama at Birmingham
Source:Eurekalert

Related biology news :

1. Experimental vaccine protects monkeys against chikungunya
2. HIV vaccine strategy expands immune responses
3. Tulane receives $15 million NIH contract to develop vaccine and treatment for deadly fever
4. UCF professors vaccine could be lethal weapon against malaria, cholera
5. Promising candidates for malaria vaccine revealed
6. Major breakthrough may pave the way for therapeutic vaccines
7. Researchers work on vaccine to improve immune system in newborns
8. Iowa State researcher produces, ships only H1N1 vaccine available for swine
9. Despite risk, older African-Americans more likely than others to avoid flu vaccine
10. Scientists create NICE solution to pneumonia vaccine testing problems
11. Bug barcode readers hold out promise of universal vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/14/2016)... http://www.apimages.com ) - ... - Renvoi : image disponible via AP Images ( ... --> DERMALOG, le leader de l,innovation ... d,empreintes digitales pour l,enregistrement des réfugiés en Allemagne. ... produire des cartes d,identité aux réfugiés. DERMALOG dévoilera ...
(Date:3/10/2016)... Pa. , March 10, 2016   Unisys Corporation ... Customs and Border Protection (CBP) is testing its biometric ... San Diego to help identify certain non-U.S. ... . The test, designed to help determine the efficiency ... environment, began in February and will run until May 2016. ...
(Date:3/8/2016)... 8, 2016   Valencell , the leading ... it has secured $11M in Series D financing. ... new venture fund being launched by UAE-based financial ... existing investors TDF Ventures and WSJ Joshua Fund. ... its triple-digit growth and accelerate its pioneering innovation ...
Breaking Biology News(10 mins):
(Date:5/17/2016)... ... May 17, 2016 , ... DryLet, ... reduction applications, announced today it will be showcasing ManureMagic™ at booth V1061 at ... featured in the Wall Street Journal last year and more recently made news ...
(Date:5/17/2016)... ... May 17, 2016 , ... PATH ... they will collaborate to bring a feeding cup to market based on a ... the Craniofacial Center at Seattle Children’s Hospital, thereby ensuring an innovative feeding option ...
(Date:5/17/2016)... Strekin AG, a start-up ... Switzerland announced today the in-licensing of ... protein kinase.      (Logo: http://photos.prnewswire.com/prnh/20160513/367502LOGO ... the necessary research foundation for the clinical development ... play fundamental roles. Pamapimod has a well-established safety ...
(Date:5/17/2016)... ... 17, 2016 , ... Yukon Medical, a leading developer of ... and Company) to receive its Global Product Innovation Supplier of the Year Award. ... contributions to advancing or supporting key BD initiatives, products, processes, and customer satisfaction. ...
Breaking Biology Technology: